Supplement Claims Rules v. Drugs, Foods: FDA Opens Free Speech Debate
This article was originally published in The Tan Sheet
Executive Summary
FDA invites public comments on the constitutionality of its approach to regulating claims for dietary supplements compared with Rx drugs and foods in a notice appearing in the May 16 Federal Register